Evidence for protean agonism of RX 831003 at α2A-adrenoceptors by co-expression with different Gα protein subunits
- 31 May 2002
- journal article
- Published by Elsevier BV in Neuropharmacology
- Vol. 42 (6), 855-863
- https://doi.org/10.1016/s0028-3908(01)00201-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inverse, protean, and ligand‐selective agonism: matters of receptor conformationThe FASEB Journal, 2001
- Modulation of 5-HT1A receptor signalling by point-mutation of cysteine351 in the rat Gαo proteinNeuropharmacology, 1999
- Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor StimulusPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,1998
- Inverse agonism and the regulation of receptor numberTrends in Pharmacological Sciences, 1997
- A three-state receptor model of agonist actionTrends in Pharmacological Sciences, 1997
- Structural Instability of a Constitutively Active G Protein-coupled ReceptorJournal of Biological Chemistry, 1997
- Pharmacological proteus?Trends in Pharmacological Sciences, 1995
- Agonist-receptor efficacy II: agonist trafficking of receptor signalsTrends in Pharmacological Sciences, 1995
- Inverse agonism: pharmacological curiosity or potential therapeutic strategy?Trends in Pharmacological Sciences, 1995
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976